Quicksilver Scientific

Due to higher than normal order volume, we are experiencing shipping delays; thank you for your understanding and patience.

0

Unsupported Browser

This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

CBD Synergies PN References

  1. Phillipis JK, et al. Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use. Washington DC, National Academies Press, 2017.
  2. Sondergaard KB, et al. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case–time–control study. Eur Heart J Cardiovasc Pharmacother. 2017; 3(2): 100-107.
  3. CNT Collaborative Group. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. The Lancet. 2013; 382(9894): 769-779.
  4. Utzeri E, Usai P. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World J Gastroenterol. 2017; 23(22): 3954-3963.
  5. Nezvalova-Henriksen K, et al. Association of prenatal ibuprofen exposure with birth weight and gestational age: A population-based sibling study. PLoS One. 2016; 11(12): e0166971.
  6. De Petrocellis L, Di Marzo V. An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab. 2009; 23(1): 1-15.
  7. Barrie N, Manolios N. The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease. Eur J Rheumatol. 2017; 4(3): 210-218.
  8. Ward SJ, et al. cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. Br J Pharmacol. 2014; 171(3): 636-645.
  9. Lichtman AH, et al. Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain. J Pain Symptom Manage. 2018; 55(2): 179-188.
  10. O’Brien, M, McDougall JJ. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids. Curr Opin Pharmacol. 2018; 40: 104-109.
  11. Urits I, et al. An update of current Cannabis-based pharmaceuticals in pain medicine. Pain Ther. 2019; 8(1): 41-51.
  12. Philpott HT, et al. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017; 158(12): 2442-2451.
  13. Schley M, et al. Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Curr Med Res Opin. 2006; 22(7): 1269-1276.
  14. Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006; 66(2): 234-246.
  15. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011; 163(7): 1344-1364.
  16. Bruni N, et al. Cannabinoid delivery systems for pain and inflammation treatment. Molecules. 2018; 23(10): 2478.
  17. Majeed S. The state of the curcumin market. Natural Products Insider. 2015.
  18. Dou Y, et al. curcumin attenuates collagen-induced inflammatory response through the “gut-brain axis.” J Neuroinflamm. 2018; 15:6.
  19. Toden S, et al. Essential turmeric oils enhance anti-inflammatory efficacy of curcumin in dextran sulfate sodium-induced colitis. Sci Rep. 2017; 7: 814.
  20. Funk JL, et al. Anti-arthritic effects and toxicity of the essential oils of turmeric (Curcuma longa L.). J Agric Food Chem. 2010; 58(2): 842-849.
  21. Nelson KM, et al. The essential medicinal chemistry of curcumin. J Med Chem. 2017; 60(5): 1620-1637.
  22. Sun M, et al. Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine (Lond). 2012; 7(7): 1085-1100.
  23. Yue GGL, et al. The role of turmerones on curcumin transportation and p-glycoprotein activities in intestinal Caco-2 cells. J Med Food. 2012; 15(3): 242-252.
  24. Antony B, et al. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci. 2008; 70(4): 445-449.
  25. Umar S, et al. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine. 2014; 21(6): 847-856.
  26. Sengupta K, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin®for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008; 10: R85.
  27. Majeed M, et al. A pilot, randomized, double‐blind, placebo‐controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res. 2019; 33(5): 1457-1468.
  28. Gupta I, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001; 67(5): 391-395.
  29. Haroyan A, et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med. 2018; 18: 7.
  30. Meins J, et al. Enhanced absorption of boswellic acids by a micellar solubilized delivery form of Boswellia extract. NFS Journal. 2018; 11: 12-16.
  31. Fidyt K, et al. β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties. Cancer Med. 2016; 5(10): 3007-3017.
  32. Mhaske DB, et al. Role of piperine as an effective bioenhancer in drug absorption. Pharm Anal Acta. 2018; 9- 7.
  33. Dzierzanowski T. Prospects for the use of cannabinoids in oncology and palliative care practice: A review of the evidence. Cancers (Basel). 2019; 11(2): 129.
  34. Rudroff T, Sosnoff J. Cannabidiol to improve mobility in people with multiple sclerosis. Front Neurol. 2018; 9: 183.
  35. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011; 72(5): 735-744.
  36. De Vita MJ, et al. Association of cannabinoid administration with experimental pain in healthy adults: A systematic review and meta-analysis. JAMA Psychiatry. 2018; 75(11): 1118-1127.
  37. Perkins K, et al. Efficacy of Curcuma for treatment of osteoarthritis. J Evid Based Complementary Altern Med. 2017; 22(1): 156-165.
  38. Bulboaca AB, et al. Preemptive analgesic and antioxidative effect of curcumin for experimental migraine. Biomed Res Int. 2017; 2017: 4754701.
  39. Daily JW, et al. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016; 19(8): 717-729.
  40. Mazieiro R, et al. Is curcumin a possibility to treat inflammatory bowel diseases? J Med Food. 2018; 21(11) [ahead of print].
  41. Delecroix B, et al. Curcumin and piperine supplementation and recovery following exercise induced muscle damage: A randomized controlled trial. J Sports Sci Med. 2017; 16(1): 147-153.
  42. Jager R, et al. Eight weeks of a high dose of curcumin supplementation may attenuate performance decrements following muscle-damaging exercise. Nutrients. 2019; 11(7): pii: E1692.
  43. Alberti TB, et al. (−)-β-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis. Int J Mol Sci. 2017; 18(4): 691.
  44. Segat GC, et al. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology. 2017; 125: 207-219.
  45. Bang JS, et al. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther. 2009; 11(2): R49.
  46. Umar S, et al. piperine ameliorates oxidative stress, inflammation and histological outcome in collagen induced arthritis. Cell Immunol. 2013; 284(1-2): 51-59.
0
Your Cart